This Edition
ARTICLE | Distillery Therapeutics
Therapeutics: Interleukin-22 (IL-22)
BC Staff
October 1, 2015 7:00 AM UTC
INDICATION: Autoimmune
TARGET/MARKER/PATHWAY:
Interleukin-22 (IL-22)
...